Machine learning strategy for identifying altered gut microbiomes for diagnostic screening in myasthenia gravis
Myasthenia gravis (MG) is a neuromuscular junction disease with a complex pathophysiology and clinical variation for which no clear biomarker has been discovered. We hypothesized that because changes in gut microbiome composition often occur in autoimmune diseases, the gut microbiome structures of p...
Main Authors: | Che-Cheng Chang, Tzu-Chi Liu, Chi-Jie Lu, Hou-Chang Chiu, Wei-Ning Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1227300/full |
Similar Items
-
Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis
by: Che-Cheng Chang, et al.
Published: (2024-12-01) -
Assessing the length of hospital stay for patients with myasthenia gravis based on the data mining MARS approach
by: Che-Cheng Chang, et al.
Published: (2023-12-01) -
Utilization of Decision Tree Algorithms for Supporting the Prediction of Intensive Care Unit Admission of Myasthenia Gravis: A Machine Learning-Based Approach
by: Che-Cheng Chang, et al.
Published: (2022-01-01) -
Clinical Predictors of Prolonged Hospital Stay in Patients with Myasthenia Gravis: A Study Using Machine Learning Algorithms
by: Che-Cheng Chang, et al.
Published: (2021-09-01) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
by: Courtney Townsel, et al.
Published: (2016-03-01)